Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00540_DB01026_nanopub.RAdgaFqVcJCmhzcnG01unDoQsjIpURtOk-kETbk6gttdY#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00540_DB01026 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00540_DB01026 label "DDI between Nortriptyline and Ketoconazole - Ketoconazole, a moderate CYP2D6 inhibitor, may increase the serum concentration of nortriptyline by increasing its metabolism. Monitor for changes in the therapeutic and adverse effects of nortriptyline if ketoconazole is initiated, discontinued or dose changed. [drugbank_resource:DB00540_DB01026]" assertion.
- drugbank_resource:DB00540_DB01026 identifier "drugbank_resource:DB00540_DB01026" assertion.
- drugbank_resource:DB00540_DB01026 title "DDI between Nortriptyline and Ketoconazole - Ketoconazole, a moderate CYP2D6 inhibitor, may increase the serum concentration of nortriptyline by increasing its metabolism. Monitor for changes in the therapeutic and adverse effects of nortriptyline if ketoconazole is initiated, discontinued or dose changed." assertion.
- drugbank:DB01026 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00540_DB01026 assertion.
- drugbank:DB00540 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00540_DB01026 assertion.